We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Brain Surgery for Epilepsy Dramatically Underutilized

By HospiMedica International staff writers
Posted on 08 May 2012
Despite the unequivocal effectiveness of brain surgery for treating uncontrolled epilepsy, the procedure has not been widely adopted, according to a new study.

Researchers from the University of California, San Francisco (UCSF; USA) performed a population-based cohort study with time trends (1990 to 2008) involving patients admitted to US hospitals for medically refractory focal epilepsy (MRFE). More...
In all, 112,026 hospitalizations for MRFE and 6,653 resective surgeries (which included lobectomies and partial lobectomies) occurred during this period. The study timeline was centered on a decade-old landmark Canadian study that showed that nearly two-thirds of all people who underwent surgery in the 1990s were seizure-free.

The results showed that a trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates. Only a few hundred patients are treated surgically each year across the United States, with UCSF performing about 50 of these operations. Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities, and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare. The study was published in the April 17, 2012, issue of Neurology.

“Part of the problem is awareness, both among patients and care providers. New anticonvulsant drugs appear on the market often enough to provide physicians with new drug combinations for their patients to try,” said lead author Edward Chang, MD, chief of adult epilepsy surgery in the UCSF department of neurological surgery and the UCSF Epilepsy Center (San Francisco, CA, USA). “The problem though is that new medications are not very effective if previous ones already failed. Brain surgery can be more daunting than having to swallow fistfuls of pills, even though surgery is much more effective for many people.”

Epilepsy is a common and diverse set of chronic neurological disorders characterized by seizures that result from abnormal, excessive, or hyper-synchronous neuronal activity in the brain. Some definitions of epilepsy require that seizures be recurrent and unprovoked, but others require only a single seizure combined with brain alterations, which increase the chance of future seizures. Epilepsy affects about 50 million people worldwide, with nearly 90% of it occurring in developing countries.

Related Links:

University of California, San Francisco
UCSF Epilepsy Center




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.